基本信息
views: 313
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
The Institute of Experimental Hematology investigates the biology of blood cell formation and function with a special focus on genetic cell modification as a new therapeutic modality.
Our research groups collaborate to form a portfolio ranging from the generation and expansion of stem cells to the control or enhancement of cell differentiation and function. We connect basic research and strong translational efforts in the field of molecular cell modification for the treatment of severe blood diseases, such as immune disorders and leukemia. The detection and prevention of risks associated with genetic cell modification and training of young scientists are important missions of our Institute.
The Institute of Experimental Hematology contributes to strong research networks of Hannover Medical School, including the DFG-funded cluster of excellence REBIRTH, the collaborative research center SFB738, and the Integrated Research and Treatment Center for Transplantation Medicine (IFB-Tx). Furthermore, we participate in the DFG-funded research priority program “mechanisms of gene vector entry and persistence” (SPP1230), several network projects supported by the BMBF, DAAD and Federal State of Lower Saxony (R2N) as well as integrated projects of the EU Horizon 2020 RECOMB and the ERC.
Our research groups collaborate to form a portfolio ranging from the generation and expansion of stem cells to the control or enhancement of cell differentiation and function. We connect basic research and strong translational efforts in the field of molecular cell modification for the treatment of severe blood diseases, such as immune disorders and leukemia. The detection and prevention of risks associated with genetic cell modification and training of young scientists are important missions of our Institute.
The Institute of Experimental Hematology contributes to strong research networks of Hannover Medical School, including the DFG-funded cluster of excellence REBIRTH, the collaborative research center SFB738, and the Integrated Research and Treatment Center for Transplantation Medicine (IFB-Tx). Furthermore, we participate in the DFG-funded research priority program “mechanisms of gene vector entry and persistence” (SPP1230), several network projects supported by the BMBF, DAAD and Federal State of Lower Saxony (R2N) as well as integrated projects of the EU Horizon 2020 RECOMB and the ERC.
Research Interests
Papers共 682 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jiangshan Xu,Pengcheng Guo, Shijie Hao,Shuncheng Shangguan, Quan Shi,Giacomo Volpe, Keke Huang,Jing Zuo, Juan An, Yue Yuan,Mengnan Cheng, Qiuting Deng,
NATURE GENETICSno. 5 (2024): 953-969
MOLECULAR THERAPY NUCLEIC ACIDSno. 1 (2024): 102157-102157
MBIOno. 2 (2024): e0330823-e0330823
Saumya Shree Gupta,Tobias Maetzig,Goedele N Maertens, Azar Sharif,Michael Rothe,Magdalena Weidner-Glunde,Melanie Galla,Axel Schambach,Peter Cherepanov, Thomas F Schulz
Journal of virologyno. 4 (2024): e0013524-e0013524
Lena Fischer-Riepe,Sareetha Kailayangiri,Katharina Zimmermann,Rita Pfeifer,Michael Aigner,Bianca Altvater,Sascha Kretschmann,Simon Voelkl,Jordan Hartley, Celine Dreger, Katja Petry,Andreas Bosio,
Cancer Researchno. 6_Supplement (2024): 6328-6328
Julia D. Suerth, Michael A. Morgan,Stephan Kloess,Dirk Heckl,Christine Neudoerfl,Christine S. Falk, Ulrike Koehl,Axel Schambach
JOURNAL OF MOLECULAR MEDICINE-JMMno. 1 (2024): 143-145
Niklas Beschorner, Paul Kuenzle,Maike Voges,Ilona Hauber,Daniela Indenbirken, Jacqueline Nakel, Sanamjeet Virdi,Peter Bradtke,Niels Christian Lory,Michael Rothe,Maciej Paszkowski-Rogacz,Frank Buchholz,
PLOS ONEno. 3 (2024): e0298542-e0298542
HARDWAREX (2024): e00509-e00509
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn